echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Children's medication: Hengrui "Cyclophosphamide Capsules" plans to be reviewed first, the first domestic product

    Children's medication: Hengrui "Cyclophosphamide Capsules" plans to be reviewed first, the first domestic product

    • Last Update: 2021-10-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 13, the CDE official website announced that Hengrui Medicine's cyclophosphamide capsules would be included in the priority review and approval.


    Cyclophosphamide (CTX) is one of the commonly used cytotoxic drugs in clinical practice.


    According to the Insight database, only injections and tablets of the same variety have been approved in China


    Competition status of cyclophosphamide varieties (Insight)

    From: Insight database

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.